Evaluating safety and acceptability of a non surgical male circumcision device and providing evidence to inform prequalification by the World Health Organization and approval by the Food and Drug Administration.
Building and strengthening networks for girl-centered programming that builds protective health, economic, cognitive, and social assets of the most off-track adolescent girls; implementing tools, conducting workshops, introducing technologies, and documenting experiences.
Understanding the social, educational, health, and economic effects of COVID-19 on adolescent girls; and integrating gender-related questions into surveys.
Deepening understanding of the diversity of experiences of child, early, and forced marriage and the effectiveness of interventions to build an evidence base for policies, programs, advocacy, and investments.
Understanding knowledge, attitudes, and practices over time during the COVID-19 outbreak; determining the impact of behavior-change prevention messages; understanding long-term impacts of the pandemic and preparedness for future disease outbreaks; and generating data to design policies and interventions.
Studying the primary factors of poor maternal newborn child health in urban informal settlements, implementing established interventions adapted for informal settlements, and organizing participatory forums for intervention stewards to sustain programs.
Addressing and evaluating programs to engage boys and men in reducing girls’ experience of gender-based violence and changing gender norms that perpetuate violence against women and girls.
Standardizing metrics for performance monitoring of frontline health worker programs; generating critical evidence that advances community health systems; and engaging existing communities of practice.
Pilot-testing and evaluating a project that integrates mental health training into a social, health, and economic asset-building program to address stigma, increase awareness of warning signs, and provide counseling.
Testing a novel male contraceptive gel containing Nestorone and testosterone applied daily by the male partner in a global Phase 2 clinical trial evaluating the efficacy, safety and acceptability of the gel over a period of 52 weeks.